Frontera Therapeutics
PrivateLast Round
Series B
Jul 19, 2022
Total Funding Raised
$195M
Company Overview
Frontera Therapeutics is a biotechnology company specializing in the development and commercialization of cost-effective recombinant virus-based gene therapies for various genetic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Frontera Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Frontera Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 19, 2022 |
Frontera Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boyu Capital | Series B |
| Creacion Ventures | Series B, Series A |
| Starr Investment Holdings | Series B |
| OrbiMed | Series B, Series A |
| Starr Investments & Benefits | Series B |
| TMCP | Series B |
| HongShan | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 22, 2025
Will present gene therapy advances at the 2025 ASGCT Annual meeting.
- Apr 22, 2025
Will present gene therapy advances at the 2025 ARVO Annual meeting.
Frontera Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Frontera Therapeutics's valuation, stock price, and market status.
